<qa>  What is the name of the combination therapy arm that is discontinued due to toxicity?Patients will continue BPM31510 alone, or in combination with gemcitabine, for a maximum of 12 cycles in the absence of intolerable toxicity and progression. If gemcitabine in the combination therapy arm is discontinued due to chemotherapy-related toxicity, patients may continue to receive BPM31510 as monotherapy. 